Free Trial

Lexaria Bioscience (LEXX) Short Interest Ratio & Short Volume

Lexaria Bioscience logo
$1.16 -0.01 (-0.85%)
Closing price 04/30/2025 04:00 PM Eastern
Extended Trading
$1.18 +0.03 (+2.16%)
As of 07:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lexaria Bioscience Short Interest Data

Lexaria Bioscience (LEXX) has a short interest of 520,200 shares, representing 3.20% of the float (the number of shares available for trading by the public). This marks a -23.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 167,802 shares to cover all short positions.

Current Short Interest
520,200 shares
Previous Short Interest
679,900 shares
Change Vs. Previous Month
-23.49%
Dollar Volume Sold Short
$743,886.00
Short Interest Ratio
5.0 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
17,559,000 shares
Float Size
16,280,000 shares
Short Percent of Float
3.20%
Today's Trading Volume
46,430 shares
Average Trading Volume
167,802 shares
Today's Volume Vs. Average
28%
Short Selling Lexaria Bioscience?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LEXX Short Interest Over Time

LEXX Days to Cover Over Time

LEXX Percentage of Float Shorted Over Time

Lexaria Bioscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025520,200 shares $743,886.00 -23.5%3.2%5 $1.43
3/31/2025679,900 shares $1.16 million +30.2%4.2%4.5 $1.71
3/15/2025522,200 shares $704,970.00 -5.1%3.2%3.3 $1.35
2/28/2025550,200 shares $808,794.00 +2.0%3.4%3.1 $1.47
2/15/2025539,400 shares $863,040.00 -11.6%3.3%3 $1.60
1/31/2025610,400 shares $1.08 million -17.4%3.8%3.3 $1.77
1/15/2025739,000 shares $1.40 million +43.6%4.5%3.8 $1.90
12/31/2024514,700 shares $1.08 million +3.1%3.2%3.5 $2.10
12/15/2024499,300 shares $1.12 million +67.4%3.1%3.5 $2.24
11/30/2024298,200 shares $620,256.00 -12.9%1.8%2.2 $2.08
11/15/2024342,400 shares $688,224.00 +23.6%2.1%2.4 $2.01
10/31/2024277,100 shares $595,765.00 +0.5%1.7%1.8 $2.15
10/15/2024275,700 shares $791,259.00 -11.4%1.7%1.7 $2.87
9/30/2024311,100 shares $948,855.00 -2.0%2.1%1.8 $3.05
9/15/2024317,500 shares $1.09 million +31.4%2.2%1.8 $3.43
8/31/2024241,700 shares $945,047.00 +54.5%1.7%1.3 $3.91
8/15/2024156,400 shares $492,660.00 -27.8%1.1%0.7 $3.15
7/31/2024216,500 shares $885,485.00 +36.4%1.5%1 $4.09
7/15/2024158,700 shares $461,817.00 No Change1.1%0.8 $2.91
6/30/2024158,700 shares $441,186.00 +3.7%1.3%0.7 $2.78
6/15/2024153,000 shares $472,770.00 -25.7%1.2%0.6 $3.09
5/31/2024205,900 shares $800,951.00 +30.7%1.7%0.5 $3.89
5/15/2024157,500 shares $485,100.00 -38.8%1.4%0.3 $3.08
4/30/2024257,200 shares $794,748.00 -41.0%2.3%0.5 $3.09
4/15/2024435,600 shares $866,844.00 -11.2%3.7%0.9 $1.99
3/31/2024490,400 shares $1.78 million -35.0%4.3%1.1 $3.63
3/15/2024754,500 shares $2.94 million +13.0%6.5%1.7 $3.90
2/29/2024667,900 shares $2.30 million -2.6%6.4%2.1 $3.45
2/15/2024685,700 shares $1.62 million +15.7%6.6%4 $2.36
1/31/2024592,800 shares $883,272.00 -10.5%6.7%4.5 $1.49
1/15/2024662,400 shares $1.00 million -11.6%7.5%4.8 $1.51
12/31/2023749,200 shares $936,500.00 -3.7%8.6%5.8 $1.25
12/15/2023778,100 shares $988,187.00 +5.9%8.9%6.4 $1.27
11/30/2023734,600 shares $1.10 million +3.2%8.6%6.3 $1.50
11/15/2023712,100 shares $954,214.00 +58.2%8.4%7.2 $1.34
10/31/2023450,000 shares $621,000.00 -2.5%6.2%4.1 $1.38
10/15/2023461,500 shares $422,318.19 +9.1%6.4%5.2 $0.92
9/30/2023422,900 shares $422,857.71 +14.5%5.8%4.9 $1.00
9/15/2023369,200 shares $321,573.20 -14.5%5.6%4.2 $0.87
8/31/2023431,900 shares $453,451.81 +0.2%6.2%4.5 $1.05
Silicon Valley Gold Rush (Ad)

A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.

Gates and Altman are betting big—see why
8/15/2023431,000 shares $478,410.00 +44.9%5.8%3.5 $1.11
7/31/2023297,500 shares $247,966.25 +3.3%4.0%1.6 $0.83
7/15/2023288,100 shares $238,460.37 +4.5%3.9%1.6 $0.83
6/30/2023275,700 shares $201,343.71 -11.0%3.7%1.8 $0.73
6/15/2023309,800 shares $213,823.96 -9.7%4.2%2.1 $0.69
5/31/2023343,000 shares $254,780.40 +31.9%4.7%2.5 $0.74
5/15/2023260,100 shares $188,520.48 -14.4%3.6%1.9 $0.72
4/30/2023303,800 shares $634,942.00 -4.4%5.7%6.5 $2.09
4/15/2023317,900 shares $693,022.00 -6.1%5.9%15.3 $2.18
3/31/2023338,500 shares $920,720.00 +4.2%6.3%16.1 $2.72
3/15/2023325,000 shares $880,750.00 -0.7%6.7%16 $2.71
2/28/2023327,300 shares $991,719.00 +3.8%6.8%16.6 $3.03
2/15/2023315,200 shares $936,207.04 +5.3%6.5%19.5 $2.97
1/31/2023299,400 shares $961,103.94 +9.5%6.2%19.6 $3.21
1/15/2023273,400 shares $757,318.00 +0.0%5.6%18.1 $2.77
12/30/2022273,300 shares $672,318.00 -2.2%5.1%17.2 $2.46
12/15/2022279,300 shares $779,219.07 -8.5%5.2%14.5 $2.79
11/30/2022305,200 shares $903,392.00 -0.6%5.7%13.4 $2.96
11/15/2022307,100 shares $738,575.50 -5.1%5.8%12.8 $2.41
10/31/2022323,600 shares $715,156.00 +3.2%6.1%8.9 $2.21
10/15/2022313,500 shares $661,485.00 -5.2%5.9%8.1 $2.11
9/30/2022330,600 shares $809,970.00 +1.2%6.2%8 $2.45
9/15/2022326,700 shares $957,231.00 -2.3%6.1%6.2 $2.93
8/31/2022334,400 shares $989,824.00 -0.1%6.2%6.2 $2.96
8/15/2022334,600 shares $1.07 million -0.1%6.2%5.6 $3.20
7/31/2022334,900 shares $904,230.00 +15.9%6.2%5.6 $2.70
7/15/2022288,900 shares $826,254.00 -33.7%5.4%3.9 $2.86
6/30/2022435,900 shares $1.30 million +3.7%8.1%0.5 $2.98
6/15/2022420,400 shares $941,696.00 +15.7%7.8%0.5 $2.24
5/31/2022363,500 shares $745,175.00 +34.1%6.8%0.4 $2.05
5/15/2022271,100 shares $555,755.00 -8.8%5.0%0.3 $2.05
4/30/2022297,300 shares $826,494.00 +14.2%5.5%0.3 $2.78
4/15/2022260,400 shares $997,332.00 -2.1%4.8%0.3 $3.83
3/31/2022266,100 shares $878,130.00 -3.8%5.0%4.6 $3.30
3/15/2022276,700 shares $868,838.00 -5.6%5.1%3.5 $3.14
2/28/2022293,100 shares $1.04 million -12.4%5.5%1 $3.55
2/15/2022334,700 shares $1.31 million -11.8%6.2%1.1 $3.90
1/31/2022379,600 shares $1.52 million +15.5%14.0%1.2 $4.00
1/15/2022328,800 shares $1.52 million -7.1%12.1%1.1 $4.61
12/31/2021353,800 shares $1.43 million -13.8%13.3%1.2 $4.03
12/15/2021410,300 shares $1.84 million +26.8%15.4%1.3 $4.49
11/30/2021323,500 shares $1.71 million -9.0%12.2%1.1 $5.30
11/15/2021355,300 shares $2.29 million -1.9%14.8%2.2 $6.44
10/29/2021362,200 shares $2.24 million -3.2%15.1%2.1 $6.19
10/15/2021374,000 shares $2.56 million +10.3%15.6%1.8 $6.84
9/30/2021339,000 shares $2.12 million -5.5%14.1%0.3 $6.26
9/15/2021358,900 shares $2.23 million +22.4%15.0%0.3 $6.21
8/31/2021293,300 shares $1.82 million -5.2%12.2%0.3 $6.22
8/13/2021309,300 shares $1.70 million No Change12.9%0.3 $5.51

LEXX Short Interest - Frequently Asked Questions

What is Lexaria Bioscience's current short interest?

Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 520,200 shares of LEXX short. 3.20% of Lexaria Bioscience's shares are currently sold short. Learn More on Lexaria Bioscience's current short interest.

What is a good short interest ratio for Lexaria Bioscience?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEXX shares currently have a short interest ratio of 5.0. Learn More on Lexaria Bioscience's short interest ratio.

What is a good short interest percentage for Lexaria Bioscience?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.20% of Lexaria Bioscience's floating shares are currently sold short.

Is Lexaria Bioscience's short interest increasing or decreasing?

Lexaria Bioscience saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 520,200 shares, a drop of 23.5% from the previous total of 679,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lexaria Bioscience's float size?

Lexaria Bioscience currently has issued a total of 17,559,000 shares. Some of Lexaria Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexaria Bioscience currently has a public float of 16,280,000 shares.

How does Lexaria Bioscience's short interest compare to its competitors?

3.20% of Lexaria Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lexaria Bioscience: Alector, Inc. (7.45%), Silence Therapeutics plc (5.41%), Coya Therapeutics, Inc. (2.16%), Immunic, Inc. (2.37%), Elutia Inc. (0.34%), Zura Bio Limited (5.59%), Genelux Co. (7.03%), OptiNose, Inc. (1.80%), Oramed Pharmaceuticals Inc. (2.04%), Pliant Therapeutics, Inc. (8.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Lexaria Bioscience stock?

Short selling LEXX is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lexaria Bioscience?

A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXX, which in turn drives the price of the stock up even further.

How often is Lexaria Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXX, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:LEXX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners